These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3701205)

  • 21. Serum magnesium levels in patients with head and neck cancer.
    Kohli GS; Bhargava A; Goel H; Yadav SP; Saini AS; Singh GP; Lal H
    Magnesium; 1989; 8(2):77-86. PubMed ID: 2755215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A comparison of serum phosphohexose isomerase and sialyl transferase activities in patients with malignant disease].
    Bayer PM; Ganzinger U; Burger EC; Gergely T; Gabl F; Moser K
    Wien Klin Wochenschr; 1977 Jan; 89(1):16-7. PubMed ID: 556872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The determination of phosphohexose isomerase in patients with cancer of breast and uterus. A comparison with other tests (author's transl)].
    Telesforo P; Rosenberg R
    Quad Sclavo Diagn; 1978 Sep; 15(3):365-72. PubMed ID: 37546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of serum phosphohexose isomerase in the diagnosis and prognosis of lung cancer].
    Galassi A; Saragoni A; Campanini A; Fabbri V
    Bronches; 1975; 25(3):177-83. PubMed ID: 1220848
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prognostic significance of serum phosphohexose isomerase in metastatic breast cancer].
    Paulick R; Caffier H
    Med Klin (Munich); 1987 May; 82(11):385-91. PubMed ID: 3600541
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of serum phosphohexose isomerase (PHI) levels in the management of head and neck malignancies.
    Verma PC; Ojha T; Yadav D; Hemani DD
    Indian J Otolaryngol Head Neck Surg; 2001 Jan; 53(1):40-6. PubMed ID: 23119750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R; Caffier H; Paulick M
    Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an oral contraceptive on serum phosphohexose isomerase activity.
    Gupta U; Khuteta KP; Gupta RC
    Indian J Physiol Pharmacol; 1983; 27(3):253-4. PubMed ID: 6668056
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum phosphoexose isomerase in cancer.
    Cunietti E; Greco M
    Tumori; 1977; 63(4):321-9. PubMed ID: 929702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer.
    Baumann M; Kappl A; Lang T; Brand K; Siegfried W; Paterok E
    Cancer Invest; 1990; 8(3-4):351-6. PubMed ID: 2207761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase.
    Gault MH; Cohen MW; Kahana LM; Leelin FT; Meakins JF; Aronovitch M
    Can Med Assoc J; 1967 Jan; 96(2):87-94. PubMed ID: 6017171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphohexose isomerase (PHI) and porcine halothane sensitivity.
    Jørgensen PF; Hyldgaard-Jensen J; Moustgaard J; Eikelenboom G
    Acta Vet Scand; 1976; 17(3):370-2. PubMed ID: 983897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined use of serum enzyme levels as tumor markers in cervical carcinoma patients.
    Patel PS; Rawal GN; Balar DB
    Tumour Biol; 1994; 15(1):45-51. PubMed ID: 8146529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular lactic dehydrogenase and phosphohexose isomerase activity in leukaemia and malignant lymphoma.
    Ho AD; Fiehn W; Hunstein W
    Br J Haematol; 1982 Apr; 50(4):637-45. PubMed ID: 7066211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphohexose isomerase activity as a tumor marker in hepatoma bearing rats (Yoshida A.H. 130).
    Neri B; Pieri A; Ciapini A; Pucci M
    Anticancer Res; 1982; 2(5):287-9. PubMed ID: 7165285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophoretic variants of 6-phosphogluconate dehydrogenase (6PGD) and phosphohexose isomerase (PHI) in different racial groups in Malaysia.
    Eng LI; Welch QB
    Hum Hered; 1972; 22(4):338-43. PubMed ID: 4647199
    [No Abstract]   [Full Text] [Related]  

  • 37. A clinico-biochemical study of phosphohexose-isomerase, aliesterase and sulfhydryl group, in 25 normal and 35 cancer suspects.
    Vaid P; Sharma DC; Shastri KD
    Indian J Cancer; 1974 Dec; 11(4):448-56. PubMed ID: 4468252
    [No Abstract]   [Full Text] [Related]  

  • 38. The activity of phosphohexose isomerase in primary breast carcinomas and response to chemotherapy in patients with metastatic disease.
    Mitchell I; Deshpande N; Millis R; Rubens RD
    Cancer Chemother Pharmacol; 1986; 17(3):289-91. PubMed ID: 3742715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum levels of phosphohexose isomerase in Cooley's disease].
    Benso L; Bonenti G
    Minerva Pediatr; 1966 Nov; 18(33):1981-2. PubMed ID: 5997826
    [No Abstract]   [Full Text] [Related]  

  • 40. [The activity of isocitra dehydrogenase and of phosphohexose isomerase in the serum of patientwith malignant tumors of the mouth cavity].
    Casella M
    Arch Stomatol (Napoli); 1968; 9(4):359-63. PubMed ID: 5267533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.